Vanguard CRPV Canine Respiratory Coronavirus Vaccine
فانغارد سي آر بي في لقاح كورونا التنفسي للكلاب
Vanguard CRPV is an inactivated monovalent viral vaccine containing killed Canine Respiratory Coronavirus (CRCoV). Indicated for the active vaccination of healthy dogs 8 weeks of age or older as an aid in reducing respiratory disease and lung lesions associated with Canine Respiratory Coronavirus infection.
Dosage Form
N/A
Product Type
Biological
Manufacturer
Package
Pack of 25 x 1 mL single-dose vials
Dosages
No dosage information available.
Withdrawal Periods
| Species | Meat (days) | Milk (days) | Eggs (days) |
|---|---|---|---|
Indications
-
Active vaccination of healthy dogs 8 weeks of age or older as an aid in the reduction of clinical signs and viral shedding caused by Canine Respiratory Coronavirus.
التحصين النشط للكلاب للمساعدة في تقليل الأعراض التنفسية وإفراز الفيروس الناجم عن فيروس كورونا التنفسي.
Contraindications
No contraindications information available.
Precautions
-
Contains gentamicin and thimerosal as preservatives. Epinephrine should be administered if anaphylaxis occurs.
يحتوي على مواد حافظة؛ توفير الأدرينالين للتعامل مع أي تفاعل حساسية فوري.
Side Effects
-
Transient mild swelling at injection site or lethargy.
تورم موضعي خفيف في موضع الحقن أو خمول عابر.
Images
Documents
-
Download
Vanguard CRPV Prescribing Information
Leaflet
Active Ingredients
Diseases
No diseases linked.
Related Products
No data available
Information has not been added yet.
Related Products By Active Ingredient
No data available
Information has not been added yet.
Companies
-
Zoetis
Manufacturer
Alternatives
No alternatives available.